Cytokinetics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $66,769 | $1,579 | $16,927 | $463 |
Gross Profit | 64,483 | -98,262 | -76,702 | -84,149 |
EBITDA | -107,820 | -136,130 | -125,043 | -135,836 |
EBIT | -110,105 | -138,430 | -127,426 | -138,247 |
Net Income | -134,370 | -161,376 | -150,020 | -160,545 |
Net Change In Cash | 66,769 | 1,579 | 16,927 | 463 |
Free Cash Flow | -132,381 | -137,281 | -66,860 | -103,955 |
Cash | 74,940 | 73,680 | 94,857 | 46,888 |
Basic Shares | 119,457 | 118,496 | 118,075 | 117,685 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,474 | $7,530 | $94,588 | $70,428 |
Gross Profit | -320,934 | -322,593 | -146,225 | -89,510 |
EBITDA | -493,483 | -456,684 | -329,400 | -176,345 |
EBIT | -503,014 | -468,576 | -337,799 | -185,982 |
Net Income | -589,526 | -526,244 | -388,955 | -215,314 |
Net Change In Cash | 18,474 | 7,530 | 94,588 | 70,428 |
Cost of Revenue | -45,484 | 29,681 | ||
Free Cash Flow | -399,796 | -415,749 | -310,851 | -191,394 |
Cash | 94,857 | 113,024 | 65,582 | 112,666 |
Basic Shares | 111,979 | 96,524 | 89,825 | 76,886 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.12 |
2025-03-31 | -$1.36 |
2024-12-31 | -$1.26 |
